Skip to Content
Morningstar
Get 14 Days Free

Aurora Cannabis Inc ACB

Morningstar Rating
Rating as of

Morningstar’s Analysis

Valuation
Currency in USD

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

Signs of Stability in Aurora’s Q4, but Extreme Uncertainty Points to Better Upside Elsewhere

Analyst Note

| Kristoffer Inton |

Aurora Cannabis' fourth-quarter results continued to be weighed down by the COVID-19 pandemic, but some signs of stability have emerged. Canadian recreational cannabis sales were still down a massive 45% from the year-ago quarter, but things are looking better as sequentially sales were up 8%. The medical market continues to help Aurora, helping drive top-line growth and average realized prices higher.

Read Full Analysis

Company Profile

Business Description

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that include Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

Contact
500-10355 Jasper Avenue
Edmonton, AB, T5J 1Y6, Canada
T +1 855 279-4652
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Jun 30, 2021
Fiscal Year End Jun 30, 2022
Stock Type —
Employees 1,643

Related

Stock Strategist Industry Reports
Still a Long Road to Legalizing Cannabis Federally
But investors can still find value in U.S. cannabis stocks.
Kristoffer Inton
Stock Analyst Update
Cannabis Stocks Rally on Schumer’s Push for Legislation
Legalization doesn’t change our estimated market potential of $85 billion by 2030.
Kristoffer Inton
Market Update
Looking Under the Hood at Robinhood
Morningstar’s Global Risk Model reveals how some of the app’s most popular stocks stack up on 11 different measures of equity-related risk.
Amy C. Arnott
Stock Analyst Update
Which Stocks Will Benefit from Cannabis' Landslide Win?
Every ballot measure was approved.
Kristoffer Inton
Stock Strategist Industry Reports
Possible Biden Win May Spur Cannabis Industry Growth
Companies with U.S. exposure are better positioned to benefit from easing prohibition.
Kristoffer Inton
Our Picks
24 Stocks for 2030
We think these companies are well positioned to benefit from one of five key trends during the next decade.
Susan Dziubinski
US Videos
A Top Investing Trend for 2030
At the Morningstar Investment Conference, we discussed why we think cannabis stocks are poised to thrive.
Kristoffer Inton
Stock Strategist Industry Reports
Covering Cannabis
We see some values, although we don’t think any of the companies have moats.
Kristoffer Inton